Kazia Therapeutics Announces Closing of $2.0 Million Registered Direct Offering
Hand-out
Press Releases
January 14, 2025

Kazia Therapeutics Announces Closing of $2.0 Million Registered Direct Offering

SYDNEY, Jan. 14, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused drug development company, today announced that it has closed its previously announced registered

bradford

The Bradford Era

Local & Social